Verapamil Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 72789-416

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Verapamil Hydrochloride (NDC 72789-416). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789416 Label (72789416)

72789416 Label (72789416)
This is a description of Verapamil HCL tablets. Each tablet contains 180 mg of extended-release film-coated Verapamil hydrochloride. The package contains 90 tablets with an expiration date of 10/2025. The tablets are oval with a breakline, marked as brown and bearing the NDC number 72789-416-90. It is advised to contact your doctor for medical advice on possible side effects and report any side effects to the FDA. The tablets should be taken as instructed by your healthcare provider, typically multiple times a day.*
FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.